Prostatis Group’s Northrop Grumman NOC Stock Holding History
Bought
Maintained
Sold
Other funds holding NOC
VCM
VPM
Prostatis Group's NOC Position: Q1 2026 in Review
Prostatis Group reduced its Northrop Grumman (NOC) stake by 5.5% in Q1 2026, selling an estimated $104K and leaving 2,581 shares worth $1.76M. The position accounts for 0.45% of the portfolio, ranked #53.
Prostatis Group first reported a position in NOC in Q4 2019 and has held it in 26 quarters since. 1,875 funds tracked by Wall St. Rank hold NOC as of Q1 2026.
- Prostatis Group held 2,581 shares of Northrop Grumman worth $1.76M as of Q1 2026.
- Prostatis Group sold 150 Northrop Grumman shares in Q1 2026, an estimated $104K.
- Northrop Grumman made up 0.45% of Prostatis Group's portfolio in Q1 2026, its #53 holding.
- Prostatis Group first reported a position in Northrop Grumman in Q4 2019 and has held it in 26 quarters since.
- 1,875 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2026.
Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.